Revenue Interest Purchase Agreement - Schedule of Revenue Interest Liability, Net Activity (Details) - OrbiMed - Purchase Agreement - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Revenue interest liability at inception		$ 125,000
Capitalized issuance costs		(625)
Interest expense	$ 13,800	4,238
Revenue interest paid	(6,225)	(493)
Revenue interest payable	(2,275)	(2,760)
Revenue interest liability, net	$ 130,660	$ 125,360